Srividya Gorantla
Research Subjects
Srividya Gorantla has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Gautam Singhvi
Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Pilani Campus, Vidya Vihar, Pilani, Rajasthan, 333031, India
5 shared publications - Tejashree Waghule
Birla Institute of Technology and Science
4 shared publications - Sunil Kumar Dubey
R&D Healthcare Division, Emami Ltd, Kolkata, India
3 shared publications - Vamshi Krishna Rapalli
Birla Institute of Technology and Science
3 shared publications - Ranendra Narayan Saha
Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani Campus, Pilani, India
2 shared publications Amit Alexander
National Institute of Pharmaceutical Education and Research (NIPER)
1 shared publication
Latest Publications
- 23 March 2022
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 19 (4) , 395-407
Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis
The current drug therapies for treating Rheumatoid Arthritis (RA) include NSAIDs, DMARDs, or biological products designed to mitigate the symptoms of the disease. These therapies with conventional ...
- 23 March 2022
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 19 (4) , 395-407
Emerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritis
The current drug therapies for treating Rheumatoid Arthritis (RA) include NSAIDs, DMARDs, or biological products designed to mitigate the symptoms of the disease. These therapies with conventional ...
- 2 December 2021
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 18 (12) , 1829-1842
Revisiting techniques to evaluate drug permeation through skin
Investigating the transportation of a drug molecule through various layers of skin and determining the amount of drug retention in skin layers is of prime importance in transdermal and topical drug...
- 2 December 2021
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 18 (12) , 1829-1842
Revisiting techniques to evaluate drug permeation through skin
Investigating the transportation of a drug molecule through various layers of skin and determining the amount of drug retention in skin layers is of prime importance in transdermal and topical drug...
- 7 July 2021
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 18 (11) , 1553-1557
CD44 receptor-targeted novel drug delivery strategies for rheumatoid arthritis therapy
Rheumatoid arthritis (RA) is a chronic systemic inflammatory condition that mainly affects the lining of the synovial joints. It can progressively cause disability and even premature death. Moreove...
- 7 July 2021
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 18 (11) , 1553-1557
CD44 receptor-targeted novel drug delivery strategies for rheumatoid arthritis therapy
Rheumatoid arthritis (RA) is a chronic systemic inflammatory condition that mainly affects the lining of the synovial joints. It can progressively cause disability and even premature death. Moreove...
- 28 October 2020
- Published by Taylor & Francis in Liquid Crystals
- Vol. 48 (7) , 991-1009
Improved skin-permeated diclofenac-loaded lyotropic liquid crystal nanoparticles: QbD-driven industrial feasible process and assessment of skin deposition
- 28 October 2020
- Published by Taylor & Francis in Liquid Crystals
- Vol. 48 (7) , 991-1009
Improved skin-permeated diclofenac-loaded lyotropic liquid crystal nanoparticles: QbD-driven industrial feasible process and assessment of skin deposition
- 23 October 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (36) , 4569-4579
Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders
Background: Skin diseases affect all the age groups of people and have an impact on patients’ physical, mental, and emotional status. Conventional topical preparation is limited with its efficacy due to low permeation, frequent application, and poor adherence to the therapy for prolong time. Objective: The objective of this review article is to address the emerging trends of nanotechnology derived lipidic carrier systems for an effective treatment for skin disorders. Methodology: Various research and review articles from reputed international journals were referred and compiled. Results and Discussion: opical drug delivery systems were found to be more effective than oral and parenteral drug delivery systems for treating skin diseases due to targeted localized applications with reduced side effects. Lipid-based nanoparticles have been found to have the potential in treating skin diseases due to the biocompatibility and the versatility of the lipids. Nanostructured lipid carriers (NLCs) have gained much attention in treating skin diseases due to improved stability of the drugs, enhanced skin permeation, retention, and better therapeutic efficacy. The review summarizes the NLCs characteristics and their application for topical delivery of various therapeutics in skin disorders. NLCs have shown great potential in effective drug delivery for the treatment of psoriasis, dermatitis, bacterial infections, and skin cancer. Its cosmetic application has opened a new area for skincare. Furthermore, safety and clinical status revealed its future commercial acceptability. Conclusion: NLCs have been found as effective lipid nanocarriers for the delivery of topical therapeutics.
- 23 October 2020
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (36) , 4569-4579
Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders
Background: Skin diseases affect all the age groups of people and have an impact on patients’ physical, mental, and emotional status. Conventional topical preparation is limited with its efficacy due to low permeation, frequent application, and poor adherence to the therapy for prolong time. Objective: The objective of this review article is to address the emerging trends of nanotechnology derived lipidic carrier systems for an effective treatment for skin disorders. Methodology: Various research and review articles from reputed international journals were referred and compiled. Results and Discussion: opical drug delivery systems were found to be more effective than oral and parenteral drug delivery systems for treating skin diseases due to targeted localized applications with reduced side effects. Lipid-based nanoparticles have been found to have the potential in treating skin diseases due to the biocompatibility and the versatility of the lipids. Nanostructured lipid carriers (NLCs) have gained much attention in treating skin diseases due to improved stability of the drugs, enhanced skin permeation, retention, and better therapeutic efficacy. The review summarizes the NLCs characteristics and their application for topical delivery of various therapeutics in skin disorders. NLCs have shown great potential in effective drug delivery for the treatment of psoriasis, dermatitis, bacterial infections, and skin cancer. Its cosmetic application has opened a new area for skincare. Furthermore, safety and clinical status revealed its future commercial acceptability. Conclusion: NLCs have been found as effective lipid nanocarriers for the delivery of topical therapeutics.